<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1008393.g001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1008393.g001</object-id>
 <label>Fig 1</label>
 <caption>
  <title>SEB administration before intraperitoneal PR8 immunization increases the magnitude of primary T
   <sub>CD8</sub> responses to select viral epitopes.
  </title>
  <p>(A) BALB/c mice were injected i.p. with PBS or with 50 μg SEB three days before they were immunized i.p. with the PR8 strain of IAV. Seven days later (B,C,E,F,G,H) or at indicated time points (D), splenic (B,C,E,F,G,H) or peripheral blood (D) T
   <sub>CD8</sub> responses to indicated PR8 epitopes were evaluated by MHC I dextramer staining (B-C), MHC I tetramer staining (D), intracellular staining for IFN-γ (E-F) or 
   <italic>in vivo</italic> cytotoxicity assays (G-H). Panels B and G illustrate representative contour and histogram plots, respectively. Error bars represent SEM, and *, **, *** and **** denote statistically significant differences with 
   <italic>p</italic>&lt;0.05, 
   <italic>p</italic>&lt;0.01, 
   <italic>p</italic>&lt;0.001 and 
   <italic>p</italic>&lt;0.0001, respectively, using unpaired, two-tailed Student’s 
   <italic>t</italic>-tests.
  </p>
 </caption>
 <graphic xlink:href="ppat.1008393.g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
